Lupin to make second acquisition in Japan

Mumbai : Mumbai-based Lupin Ltd will acquire Tokyo-based I’rom Pharmaceuticals (IP) for an undisclosed amount to expand its footprint in the country. The transaction would be done through Lupin's Japanese subsidiary Kyowa Pharmaceutical Industry Co, Ltd (Kyowa), which it had acquired in 2007..

IP, subsidiary of I’rom Holdings Co, is a speciality injectable drug maker and its annual sales for the year ended March 2011 was ¤5.36 billion ($69.7 million). It has a significant presence in the DPC (diagnosis procedure combination) hospitals within Japan.